Key Metrics
CiteScore 

4
Impact Factor 

< 5
Scite Index 

0.92 5-Year SI

SNIP 

1.22
Recommended pre-submission checks
Powered by 

Topics Covered on Pharmaceuticals
Pharmaceuticals Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | MDPI |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | CHF 2200 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2004 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Pharmaceuticals ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pharmaceuticals
Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization
- 1 Aug 2026
- Pharmaceuticals
Exploration of Development Parameters for IgG Microspheres Using an Automated Platform for High-Throughput Formulation Screening
- 1 Aug 2026
- Pharmaceuticals
Drug Provocation Tests with Washout Intervals for Delayed Hypersensitivity Reactions: A Real-World Retrospective Analysis
- 31 Jul 2026
- Pharmaceuticals
Effect of Formulation and Process Variables on the Stability and Quality Attributes of Digoxin Formulations
- 29 Jul 2026
- Pharmaceuticals
Computational and Cellular Evaluation of the Anti-Melanogenic Potential of Gancidin W: Integrating Network Pharmacology and Free-Energy Analyses
- 29 Jul 2026
- Pharmaceuticals
RETRACTED: Ibrahim et al. Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity. Pharmaceuticals 2020, 13, 393
- 27 Jul 2026
- Pharmaceuticals
Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization
- 1 Aug 2026
- Pharmaceuticals
Exploration of Development Parameters for IgG Microspheres Using an Automated Platform for High-Throughput Formulation Screening
- 1 Aug 2026
- Pharmaceuticals
Drug Provocation Tests with Washout Intervals for Delayed Hypersensitivity Reactions: A Real-World Retrospective Analysis
- 31 Jul 2026
- Pharmaceuticals
Effect of Formulation and Process Variables on the Stability and Quality Attributes of Digoxin Formulations
- 29 Jul 2026
- Pharmaceuticals
Computational and Cellular Evaluation of the Anti-Melanogenic Potential of Gancidin W: Integrating Network Pharmacology and Free-Energy Analyses
- 29 Jul 2026
- Pharmaceuticals
RETRACTED: Ibrahim et al. Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity. Pharmaceuticals 2020, 13, 393
- 27 Jul 2026
- Pharmaceuticals